Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 46, Issue 6, 2013, Pages 713-718

  Porto, Juliana Pena ^a   Santos, Rosana Oliveira ^a   Filho, Paulo Pinto Gontijo ^a   Ribas, Rosineide Marques ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Attributable mortality; Bloodstream infection; Methicillin resistant Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ADULT; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIDDLE AGED; MORTALITY; NASOGASTRIC TUBE; PARENTERAL NUTRITION; PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SURGICAL INFECTION; TRACHEOSTOMY; URINARY TRACT INFECTION;

ADULT; BACTEREMIA; BRAZIL; CROSS INFECTION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 84892738875     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0199-2013     Document Type: Article

References (26)

1. Boyce JM. Are the epidemiology and microbiology of methicillinresistant Staphylococcus aureus changing? JAMA 1998; 279:623-624.
2. Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006; 12:1991-1993.
3. Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin Microbiol Infect 2006; 12:844-852.
4. Wenzel RP, Perl TM. The significance of nasal carriage of S.A. and the incidence of postoperative wound infection. J Hosp Infect 1995; 31: 13-24.
5. Gastmeier P, Kampf G, Wischneswski N, Hauer T, Sshulgen G, Schumacher G, et al. Prevalence of nosocomial infection in representative German hospitals. J Hosp Infect 1998; 38:37-49.
6. Carvalho RH, Gontijo Filho PP. Epidemiologically relevant antimicrobial resistant phenotypes in pathogens isolated from critically ill patients in a Brazilian universitary hospital. Braz J Microbiol 2008; 39:623-630.
7. Ribas RM, Freitas C, Gontijo Filho PP. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia in a tertiary care hospital: Risk factors, overall mortality and antimicrobial resistance. Int J Med Sci 2009; 1: 412-417.
8. Selvey LA, Whiby M, Johnson B. Nosocomial methicillin resistant Staphylococcus aureus bacteremia: Is it anyworse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol 2000; 21:645-648.
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infection in the acute care setting. AJIC 2008; 36:309-332.
10. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillinresistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 58:182-189.
11. World Health Organization. ATC/DDD Classification (temporary). WHO drug information. 2000; 14:32-36.
12. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
13. Simor AE, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey M, et al. Canadian Nosocomial Infection Sureveillance Program, Health Canada. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001; 165:21-26.
14. Thompson DS. Methicillin-resistanat Staphylococcus aureus in a general intensive care unit. J R Soc Med 2004; 97:521-526.
15. Ferrara AM. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus. Intl J Antimicrobiol Agents 2007; 02:011.
16. McGowan Jr JE. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull N Y Acad Med 1987; 63:253-268.
17. Shlaes DM, Gerding DN, John JR, Craic WA, Bornsteins DL, Duncan RA, et al. Society of Healthcare Epidemiology of American and Infection Disease Society of American Joint Committee on the Prevention of Antimicrobial Resistance. Guidelines for the Prevention of Antimicrobial Resistance in Hospitals. Clin Infect Dis 1997; 25:584-599.
18. Pluss-Suard C, Pannatier A, Kronenberg A, Muhlemann K, Zanetti G. Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. J Hosp Infect 2011; 79:166-171.
19. Moreira M, Medeiros EAS, Pignatari ACS, Wey SB, Cardo DM. Efeito da infecção hospitalar da corrente sanguínea por Staphylococcus aureus resistente à oxacilina sobre a letalidade e o tempo de hospitalização. Ver Assoc Med Bras 1998; 44:263-268.
20. Moreira MR, Ribas RM, Rodrigues AAA, Gontijo Filho PP. Consumo de antibióticos e etiologia de pneumonia associada à ventilação em pacientes internados na Unidade de Terapia Intensiva do Hospital de Clínicas da Universidade Federal de Uberlândia. Rev Pannam Infect 2009; 11: 11-16.
21. National Healthycare Safety Network (NHSN) annual update: antimicrobialresistant pathogens associated with healthycare-associated infections: annual summary of data reported to the NHSN at the Center for Disease Control and Prevention, 2006-2007; 2008.
22. Cosgrove S, Sakoulas G, Perencevich R, Schwaber MJ, Karchmer AW, Careli Y. Comparison of mortality associated with methicillin-resistant and methicillin susceptible S. aureus bacteraemia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
23. Gash O, Ayats J, Angeles Domingues M, Tubau F, Liñares J, Peña C, et al. Epidemiology og methicillin-resistante Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital. Medicine 2011; 90:319-327.
24. Park SY, Son JS, Oh IH, Choi JM, Lee MS. Clinical impact oh methicillinresistant Staphylococcus aureus bacteremia based on propensity scores. Infection 2011; 39:141-147.
25. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-174.
26. Naves KSC, Trindade NV, Gontijo Filho PP. Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units. Rev Soc Bras Med Trop 2012; 45:189-193.